Hubei Xingfa Chemicals Group Co., Ltd. (600141)

Individual Stock Analysis Report | Industry: Phosphorus Chemicals/Fine Chemicals | Report Date: September 13, 2026 | The research notes do not provide a clear price cut-off date/time, so the specific data date cannot be confirmed

This report is automatically compiled and generated by AI based on public information, for reference only, and does not constitute investment advice.

1. Core Summary

Xingfa Group (600141.SH) achieved operating revenue of RMB 17.452 billion in H1 2026, up 19.37% YoY, with net profit attributable to parent of RMB 836 million, up 14.97% YoY, and non-GAAP net profit attributable to parent growing even faster at 30.91%. Q2 single-quarter revenue reached RMB 10.000 billion and net profit attributable to parent reached RMB 579 million, up 34.20% and 125.59% QoQ respectively, indicating a clear recovery in performance after Q1 net profit attributable to parent declined 17.37% YoY. This is the most decision-relevant fact at present, showing that the company's profitability has shown an inflection-point improvement from the full-year 2025 trend of a 6.83% YoY decline in net profit attributable to parent.

Alongside the profit improvement, growth quality indicators have diverged markedly. In H1 2026, net cash flow from operating activities was -RMB 733 million, compared with positive RMB 123 million in the same period last year, turning from positive to negative; accounts receivable increased 66.64% from the beginning of the year; financial expenses increased 43.22% YoY. The H1 2026 gross margin was 16.46% (+0.02pct YoY) and net margin was 5.73% (+0.34pct YoY), with limited improvement in profitability indicators, while the deterioration in cash flow and accounts receivable indicators suggests a time lag between revenue recognition and cash collection.

In terms of business structure, the company's phosphorus chemicals industry chain is advancing on multiple fronts: phosphate rock maintains high prosperity, the glyphosate industry is recovering, the organosilicon industry is promoting coordinated production cuts to support prices with the DMC price center moving upward, specialty chemicals production and sales continue to ramp up, and the new energy business has signed a long-term lithium iron phosphate cooperation agreement with Qinghai FinDreams, a wholly-owned grandchild company of BYD (annual supply of no less than 80,000 tons from the Yichang base, and after subsequent bases are put into production, total annual supply of no less than 250,000 tons). However, the fertilizer segment is clearly under pressure, showing a "price without market" pattern due to the suspension of phosphate fertilizer exports and the supply-guarantee and price-stabilization policy. In 26H1, the sulfur procurement price rose 152% YoY to RMB 4,411/ton, the fertilizer segment gross margin was -2.57% (-9.16pct YoY), and the main entity Yidu Xingfa Chemical suffered a loss of RMB 167 million.

At the capital operation level, the company has completed the cancellation of repurchased shares, with total share capital reduced from 1.2017 billion shares to 1.1962 billion shares (5.5762 million shares cancelled on 2026-09-08); at the same time, it plans to raise no more than RMB 3 billion through a private placement to no more than 35 specific targets, of which RMB 1.760 billion is invested in the Qiaogou phosphate rock 2.8 million tons/year mining project, RMB 650 million is invested in the 5 million tons/year ore dressing project (Phase I), and approximately RMB 590 million is used to repay bank loans. The controlling shareholder Yichang Xingfa plans to subscribe with its own cash for no less than RMB 100 million and no more than RMB 200 million. This private placement has currently only been approved by the board of directors; the shareholders' meeting has not yet been convened, and SSE review and CSRC registration have not been completed. Whether it can ultimately be implemented, as well as the issue price and quantity, are all uncertain.

2. Company Overview

2.1 Basic Information

2.2 Main Business and Product Layout

• Phosphorus chemicals series products (including glyphosate and other pesticide products)
• Phosphate rock mining and sales
• Fine chemicals and new materials (involving layout in emerging fields such as optical fiber and storage; the research notes mention that the company obtained an invention patent authorization related to lithium manganese iron phosphate cathode materials)

2.3 Industry Chain Upstream/Downstream Position and Cost-Profit Structure

Xingfa Group is an enterprise in the phosphorus chemicals industry, with business covering industry chain links from phosphate rock resource mining to phosphorus chemical products such as glyphosate. The research notes show that the company is further enhancing its resource advantages through the acquisition of phosphate mines and is extending into new material fields such as optical fiber, storage, and lithium manganese iron phosphate cathode materials. The research notes do not provide complete specific data on upstream/downstream cost structure, supplier concentration, or customer concentration. The following content is presented faithfully based on existing information, with missing items marked.

• The research notes do not provide specific data on the company's specific raw material procurement category composition, supplier concentration, or procurement price bargaining power.
• The research notes mention that the company plans to acquire phosphate mines to further enhance resource advantages (Source: Great Wall Securities 2025 semi-annual report review), indicating that phosphate rock resources are an important upstream link for the company.
• The recovery of the glyphosate industry and the stabilization of phosphate rock prices are mentioned in brokerage research reports (Source: Great Wall Securities 2025 semi-annual report review, BOC Securities research report), reflecting that upstream phosphate rock prices affect the company's costs and profitability.
• The research notes do not provide specific data such as the combined proportion of the company's top five customers or customer concentration.
• The research notes do not provide specific data such as the industry distribution of the company's downstream customers or sales regional structure.
• The research notes mention the recovery of the glyphosate industry (Source: Great Wall Securities 2025 semi-annual report review), reflecting that changes in downstream demand for products such as glyphosate affect the company's operations.
• The research notes mention "Xingfa Group (600141) 2025 Q3 Report Brief Analysis: Revenue and net profit both grew YoY, the company's accounts receivable volume is relatively large" (Source: Stockstar), but the notes do not provide specific quantitative data such as accounts receivable turnover days or the ratio of accounts receivable to revenue or net profit, making it impossible to further verify working capital occupation.
• The research notes do not contain specific data on the combined proportion of the company's top five customers or supplier concentration; this field's data is missing. The research notes also do not contain cross-verifiable concentration sources, and it is recommended to refer to the company's latest annual report disclosure.

Xingfa Group is positioned in the upstream resource and midstream processing links of the phosphorus chemicals industry chain, owning phosphate rock resources and extending downward to phosphorus chemical products such as glyphosate and fine chemical new materials. The research notes do not provide sufficient data on cost structure, bargaining power, or gross margin trends, making it impossible to make a data-supported judgment on its specific positioning on the smile curve and the drivers of profit margin improvement.

3. Financial Data and Valuation Analysis

3.1 Recent Operating Performance

Data sources are the company's 2026 semi-annual report (disclosed 2026-08-24/25) and public materials such as Stockstar's key indicators page and Baidu Stock's financial page, with multiple sources corroborating each other. 2026Q2 single quarter: revenue RMB 10.000 billion, +35.29% YoY, +34.20% QoQ; net profit attributable to parent RMB 579 million, +39.10% YoY, +125.59% QoQ; non-GAAP RMB 660 million, +51.2% YoY; Q2 gross margin 18.53%, net margin 6.65% (Source: Southwest Securities, Kaiyuan Securities, CICC research reports). 2026H1 non-GAAP net profit attributable to parent RMB 871 million, +30.91% YoY; gross margin 16.46% (+0.02pct YoY), net margin 5.73% (+0.34pct YoY); basic earnings per share RMB 0.71; interim dividend proposed at RMB 2 per 10 shares (tax included), expected dividend distribution RMB 239 million, accounting for 28.63% of H1 net profit attributable to parent. 2025 non-GAAP net profit attributable to parent RMB 1.430 billion, -10.62% YoY; 2025 gross margin 17.96% (-1.56pct YoY), net margin 5.50%. Net assets per share: RMB 23.36 as of 2026-06, RMB 22.07 as of 2025-12; total share capital increased to 1.202 billion shares after the early redemption and conversion of the RMB 2.8 billion Xingfa Convertible Bond, with net assets of RMB 27.485 billion at the end of H1. Uncertainties to note: there is a source discrepancy in the 2025 revenue YoY growth rate, with Stockstar/company figures at +3.18% and Guotai Haitong research report (2026-04-10) stating +3.81%. Based on 2024's RMB 28.396 billion → 2025's RMB 29.300 billion, the calculation should be +3.18%, so +3.18% is adopted; the Guotai Haitong figure is suspected to be a typo. In addition, the operating cash flow turning from positive to negative (-RMB 733 million), accounts receivable +66.64% from the beginning of the year, and financial expenses +43.22% require simultaneous attention.

The latest 2026H1 revenue and net profit attributable to parent both grew (+19.37%/+14.97%), with non-GAAP growth even faster (+30.91%), and Q2 single-quarter improved significantly QoQ, with Q2 revenue +34.20% QoQ and net profit attributable to parent +125.59% QoQ. However, operating cash flow turned from positive to negative (-RMB 733 million), accounts receivable +66.64% from the beginning of the year, and financial expenses +43.22%; growth quality and cash flow conditions need to be monitored alongside performance growth.

3.2 Profit Forecast

Forecast data comes from approximately 16-17 institutional research reports over the past six months, with main sources including the Tonghuashun iNews institutional rating summary page (2026-08-25, 08-28, 09-03) and research reports from Kaiyuan Securities (2026-08-25), CICC (2026-08-25), Orient Securities (2026-08-18), Southwest Securities (2026-09-02), Guotai Haitong (2026-04-10), BOC Securities (2026-04-10), etc. Details by institution: Huatai Securities 2026E RMB 2.076 billion; Southwest Securities 2026E RMB 1.918 billion; China Merchants Securities 2026E RMB 2.021 billion; Huayuan Securities 2026E RMB 2.039 billion; Huachuang Securities 2026E RMB 1.927 billion; Orient Securities 2026-2028E RMB 2.297/2.539/2.913 billion; Huaan Securities 2026E RMB 2.041 billion; Zhongtai Securities 2026E RMB 2.213 billion; Kaiyuan Securities 2026-2028E RMB 2.034/2.682/3.024 billion; CICC 2026E/2027E RMB 1.969/2.667 billion; Changjiang Securities 2026-2028E RMB 1.927/2.627/3.225 billion; Huajin Securities 2026-2028E RMB 2.276/2.619/3.080 billion; China Merchants Securities (2026-05-03) 2026-2028E RMB 2.037/2.554/2.944 billion; Great Wall Securities 2026-2028E RMB 2.387/2.585/2.859 billion; CITIC Securities 2026-2028E RMB 2.220/2.733/3.300 billion; Guotai Haitong 2026-2028E RMB 2.132/2.410/2.450 billion; Huaxin Securities 2026-2028E RMB 2.279/2.657/2.884 billion; BOC Securities 2026-2028E RMB 2.245/2.680/2.970 billion; Guosen Securities 2026-2028E RMB 1.806/2.024/2.201 billion. Uncertainties to note: different institutions have significant divergence in 2026E net profit (lowest RMB 1.806 billion/1.918 billion, highest RMB 2.418 billion), and many were downgraded after the August semi-annual report release (e.g., Kaiyuan Securities downgraded 2026E from RMB 2.327 billion to RMB 2.034 billion due to the cyclical sector downturn since Q3; CICC downgraded 2026/2027 by 13.8%/5.1% to RMB 1.969/2.667 billion), so the average has limited reference significance and represents dynamic forecasts still being revised downward after report disclosure. Southwest Securities (2026-09-02) stated it forecasts a compound annual growth rate of 25.06% in net profit attributable to parent over the next three years.

3.3 Valuation Level and Institutional Ratings

Stock price approximately RMB 29.25 (Baidu Stock 09-11 close RMB 29.25, -4.22%); cross-verification: Kaiyuan Securities 2026-08-25 research report gives 2026-2028 PE of 17.4/13.2/11.7x based on the then current stock price, implying a stock price of approximately RMB 29.4 (1.69×17.4), basically consistent with RMB 29.25. Total market capitalization based on total share capital of 1.202 billion shares × approximately RMB 29.3 ≈ RMB 35.0-35.3 billion (estimated). Dynamic PE (based on institutional consensus): 2026E approximately 16.7-18.4x, 2027E approximately 13.2-15.8x (CICC: currently corresponding to 18.4x/13.6x for 2026/2027; Kaiyuan: 17.4/13.2/11.7x). PE(TTM) (estimated by this memo): using 2025 RMB 1.492 billion − 2025H1 RMB 727 million + 2026H1 RMB 836 million = RMB 1.601 billion as trailing twelve-month net profit attributable to parent, with market capitalization of approximately RMB 35.3 billion → PE(TTM) ≈ 22x, which is an estimate and not officially disclosed. PB (estimated): net assets per share approximately RMB 23.36 (2026-06) → PB ≈ 1.25x, which is an estimate. Dividend: 2025 annual dividend RMB 0.5 per share (tax included, totaling approximately RMB 598 million), 2026 interim RMB 0.2 per share. Average institutional target price approximately RMB 36, implying approximately 15%-20% upside (uniformly based on August-September research reports, not the latest real-time close). Uncertainties to note: 1) Stock price sources vary, Baidu Stock 09-11 shows RMB 29.25, Simply Wall St (data updated 2026-08-28) shows total market capitalization CN¥37.4b, with 1.20 billion outstanding shares implying a stock price of approximately RMB 31, MarketScreener January data shows approximately RMB 38.85; the recent (late August-early September) range of RMB 29-31 is most credible, but no authoritative exchange closing price page was directly read, so market cap/PE/PB all contain estimation components; it is recommended to refer to market terminals. 2) PE(TTM) and PB are estimated by this memo based on public data; PE(2026E/2027E) comes from brokerage statements and are forecast values rather than disclosed values. 3) Target prices are all single-institution forecasts (including PE multiple assumptions), not exchange or association figures; the consensus average is a simple statistic of multiple brokerages and does not represent actual future results. 4) There is also old data from MarketScreener/S&P Capital IQ dated 2026-01-20: at that time, the average rating of 6 analysts was BUY, average target price RMB 33.03, reference closing price RMB 38.85 (at that time the target price was below the stock price, showing downside); this consensus is January data that has been superseded by new August-September research reports and should only be used as historical reference, not mixed with the latest consensus.

4. Recent News and Announcements

4.1 Share Buyback Implementation Completed and Changed to Cancellation, Total Share Capital Reduced to 1.196 Billion Shares

Xingfa Group (600141.SH) approved a buyback plan on 2026-01-20/21 through the 13th meeting of the 11th Board of Directors, proposing to repurchase through centralized bidding with a total fund amount of no less than RMB 200 million and no more than RMB 400 million, with a price ceiling of RMB 50/share, and a period from 2026-01-20 to 2026-04-19; the first buyback was implemented on 2026-01-27. The buyback was completed on 2026-04-19, with actual repurchase of 5,576,200 shares, accounting for 0.46% of total share capital, at a transaction price range of RMB 36.732-42.05/share, average price RMB 39.62/share, with total funds paid of RMB 220.9452 million (excluding transaction fees). During the buyback period, "Xingfa Convertible Bond" converted 98,481,955 shares, and total share capital increased from 1,103,257,902 shares to 1,201,739,857 shares. On 2026-07-05, the board of directors and on 2026-07-22, the extraordinary shareholders' meeting approved the "Proposal on Changing the Use of Repurchased Shares and Cancelling Them," changing the original "used to maintain company value and shareholder rights" to "used for cancellation and reduction of registered capital," and published a creditor notice announcement on 2026-07-23 (creditor claim period 2026-07-23 to 2026-09-05). On 2026-09-08, 5,576,200 shares were officially cancelled, with total share capital changed from 1,201,739,857 shares to 1,196,163,657 shares, and registered capital reduced from RMB 1.2017 billion to RMB 1.1962 billion. After cancellation, the shareholding ratios of shareholders holding 5% or more increased passively: Yichang Xingfa from 18.42% to 18.50%, Zhejiang Jinfanda from 14.65% to 14.72%. (Announcement No. Lin 2026-090, Source: China Securities Journal, CS.com.cn, Sina Finance)

4.2 Plans to Raise No More Than RMB 3 Billion Through Private Placement to No More Than 35 Specific Targets, Controlling Shareholder Participates in Subscription

On 2026-08-06, the 19th meeting of the 11th Board of Directors of Xingfa Group approved multiple proposals (Announcement No. Lin 2026-074, etc.), proposing to issue A-shares to no more than 35 specific targets including controlling shareholder Yichang Xingfa, with total fundraising not exceeding RMB 3 billion. Fundraising destinations: RMB 1.760 billion for the Qiaogou phosphate rock 2.8 million tons/year mining project; RMB 650 million for the Qiaogou phosphate rock 5 million tons/year ore dressing project (Phase I); approximately RMB 590 million for repaying bank loans. The pricing benchmark date is the first day of the issuance period, with the issue price not lower than 80% of the average price of the previous 20 trading days; the number of shares issued shall not exceed 30% of the total share capital before issuance (i.e., no more than 360,521,957 shares). Controlling shareholder Yichang Xingfa plans to subscribe with its own cash for no less than RMB 100 million and no more than RMB 200 million, locked up for 36 months; other targets locked up for 6 months. On the same day, the "Three-Year (2026-2028) Shareholder Return Plan" was launched. On 2026-08-07, announcements were made on the feasibility analysis of fundraising use, diluted immediate returns and filling measures, and the special report on the use of previous fundraising (Lin 2026-076~081); the board of directors decided not to convene the shareholders' meeting for the time being, which needs to be determined separately. As of early August, only board approval had been obtained; the shareholders' meeting has not yet been convened, and SSE review and CSRC registration have not been completed. The final issue price, quantity, and whether it can be implemented are all uncertain.

4.3 2026 Semi-Annual Report: Revenue RMB 17.452 Billion, Up 19.37% YoY; Net Profit Attributable to Parent RMB 836 Million, Up 14.97% YoY

Approved by the board of directors on 2026-08-21 and disclosed on 2026-08-24/25, the 2026 semi-annual report: operating revenue RMB 17.452 billion (+19.37% YoY), net profit attributable to parent RMB 836 million (+14.97% YoY), non-GAAP net profit attributable to parent RMB 871 million (+30.91% YoY), basic earnings per share RMB 0.71; net cash flow from operating activities -RMB 733 million (same period last year +RMB 123 million). Among this, Q2 revenue RMB 10.000 billion, net profit attributable to parent RMB 579 million (+39.10%, +125.59% QoQ). For comparison: 2025 annual report net profit attributable to parent RMB 1.492 billion (-6.83% YoY); 2026 Q1 report net profit attributable to parent RMB 256.6 million (-17.37% YoY).

4.4 2026 Interim Profit Distribution Plan: RMB 2 per 10 Shares, Expected Distribution RMB 239.23 Million

On 2026-08-21, the board of directors of Xingfa Group approved the 2026 interim profit distribution plan (Lin 2026-086): RMB 2 per 10 shares (tax included), based on 1,196,163,657 shares after deducting 5,576,200 shares in the repurchase special account, expected distribution of RMB 239.23 million, accounting for 28.63% of H1 net profit attributable to parent, still subject to shareholders' meeting review. The semi-annual report dividend is a "proposal" and still requires shareholders' meeting review; the buyback cancellation has been completed (2026-09-08) as a confirmed matter.

4.5 Employee Stock Ownership Plan Increase and Important Shareholder Increase

2026 Employee Stock Ownership Plan: on 2026-06-12, increased 11,889,325 shares through centralized bidding, average transaction price RMB 30.19/share (East Money executive/related party shareholding change records). Among the top ten shareholders in the semi-annual report, the 6th is "Xingfa Group-2026 Employee Stock Ownership Plan" (0.99%), and the 10th is "Xingfa Group-2025 Employee Stock Ownership Plan" (0.72%). Important shareholder increase: Zhejiang Jinfanda Biochemical Co., Ltd. completed an increase, cumulatively increasing 1.42% of shares (Zhitong Finance related reading, date shown 06-24; on 2026-06-24, People's Finance/ Securities Times reported "among 77 companies that have implemented buybacks and important shareholder increases this year, Xingfa Group's important shareholder increase and completed buyback amounts are both above RMB 100 million"). Executive increase: Supervisor Zheng Lei increased 15,000 shares (related reading date 05-23); Development Strategy Committee member Jiang Chunqian bought 8,000 shares in the secondary market on 2025-12-18 at an average price of RMB 32.91 (belongs to 2025, as background). Note: The details of Zhejiang Jinfanda's increase have not been verified against the original special announcement for the specific amount and start/end dates, and are items pending cross-verification; the employee stock ownership plan's 11,889,325 shares/RMB 30.19 average price comes from East Money records, and it is recommended to refer to the company's employee stock ownership plan transfer announcement.

4.6 Equity Pledge Situation (as of 2026-09-11)

As of 2026-09-11, Xingfa Group's total pledge ratio was 6.60%, total pledged shares 79 million, total pledge transactions 8. The main pledgers are controlling shareholder Yichang Xingfa (23 million shares pledged since 2026-06-29, accounting for 10.39% of its holdings) and Zhejiang Jinfanda (cumulative pledge of 56 million shares, accounting for approximately 31.80% of its holdings); on 2026-07-13, Zhejiang Jinfanda released 7 million shares from pledge.

4.7 External Investment: Establishment of Three Gorges Xing'an Advanced Materials Seed Fund and Hubei Xingfa Investment Co., Ltd.

On 2026-06-07, announced the joint establishment of "Three Gorges Xing'an Advanced Materials Seed Fund" with Yichang Yuehe Equity Investment Fund Management Co., Ltd. etc., with total subscribed capital of RMB 200 million, with the company as LP contributing RMB 80 million with its own funds, accounting for 40%; focusing on phosphogypsum pollution prevention and comprehensive utilization, microelectronics key chemicals, phosphorus/silicon-based high-end chemicals, etc. (announcement date 2026-06-08). On 2026-08-06/07, proposed to jointly contribute to the establishment of "Hubei Xingfa Investment Co., Ltd." (tentative name) with controlling shareholder Yichang Xingfa and controlled subsidiary Xingfu Electronics, with registered capital of RMB 150 million, with the company contributing RMB 76.50 million, accounting for 51%, engaged in equity investment/industrial investment; constitutes a related-party transaction (Lin 2026-075). Also approved the "Proposal on Joint Investment with Related Parties and Related-Party Transaction."

4.8 New Energy Cooperation: Signed Long-Term Lithium Iron Phosphate Cooperation Agreement with Qinghai FinDreams, a Wholly-Owned Grandchild Company of BYD

Previously (2025-12-04), a subsidiary signed an 80,000 tons/year lithium iron phosphate commissioned processing agreement with Qinghai FinDreams, a wholly-owned grandchild company of BYD; the 2026 semi-annual report disclosed that wholly-owned subsidiary Xingshun New Materials signed a long-term lithium iron phosphate cooperation agreement with Qinghai FinDreams, with annual supply of no less than 80,000 tons from the Yichang base, and after subsequent bases are put into production, total annual supply of no less than 250,000 tons.

4.9 "Xingfa Convertible Bond" Triggered Redemption Clause and Was Delisted

"Xingfa Convertible Bond" triggered the redemption clause, with 2026-02-26 as the last trading day and 2026-03-03 as the last conversion day; unconverted portions were forcibly redeemed at RMB 100.6699/unit and subsequently delisted (announcement on 2026-03-03). Conversion led to multiple "debt-to-equity listing" share capital changes from January to March 2026. Previous fundraising: RMB 2.8 billion convertible bond issued in September 2022, with fundraising projects (200,000 tons/year lithium iron phosphate, 100,000 tons/year wet-process phosphoric acid purification technical renovation, 80,000 tons/year functional silicone rubber, repayment of borrowings); cumulative use of RMB 2.5705 billion as of 2026-06-30 (Lin 2026-087).

4.10 External Guarantee Progress: Guarantee Balance RMB 13.492 Billion, Accounting for 61.31% of the Latest Audited Net Assets

On 2026-09-10, announced August 2026 guarantee progress (Lin 2026-091); as of 2026-08-31, the company and its controlled subsidiaries had total external guarantees of RMB 20.609 billion and guarantee balance of RMB 13.492 billion, accounting for 93.64% and 61.31% of the latest audited net assets respectively, with no overdue guarantees. Note: The total guarantee amount is for "the company and its controlled subsidiaries," and the high proportion of net assets should be understood in conjunction with the specific guaranteed entities (mostly consolidated subsidiaries), and should not be directly equated with external risk exposure.

4.11 Institutional Research and Investor Relations Updates

On 2026-08-07, received 134 institutions for research (disclosed 2026-09-01); on 2026-04-23, received 14; on 2026-01-09, received 69. On 2026-06-11, due to disclosure on the investor interaction platform of information such as "sodium hypophosphite production capacity for storage components of 20,000 tons/year, mastering indium phosphide synthesis technology, high-purity D4 for optical fiber," the stock price hit the daily limit (media stcn DataBao report). This is the interaction platform's statement, not a formal announcement, and attention should be paid to the nature of its disclosure. On 2026-06-15 and 2026-06-25, it twice appeared on the Dragon-Tiger List (cumulative three-day price deviation reaching 20%).

4.12 Industry and Policy-Related Updates

Fertilizer business: In H1 2026, affected by "suspension of phosphate fertilizer exports and supply-guarantee and price-stabilization policy," showing a "price without market" pattern; sulfur and other raw material prices rose sharply (26H1 sulfur procurement price +152% YoY to RMB 4,411/ton), squeezing phosphate fertilizer profitability; fertilizer segment gross margin -2.57% (-9.16pct YoY); the company's main entity Yidu Xingfa Chemical suffered a loss of RMB 167 million. Organosilicon: In H1 2026, the industry's "anti-involution" promoted coordinated production cuts to support prices, with the DMC price center moving upward. Note: The above policy statements come from brokerage research reports and semi-annual report paraphrasing; no separate latest regulatory department policy original text was retrieved this time, and policy details should be based on official documents.

4.13 Time Anchor and Data Limitations Statement

The latest verifiable trading day this time is 2026-09-11 (close RMB 29.25, -4.22%); no updates after mid-September were retrieved, and "recent" is defined with this date as the upper limit. Some sources are second-hand financial reprints (Stockstar "Stock Encyclopedia," 9fzt, Jiemian "Youlianyun," etc.); key figures have been compared and found consistent with company announcements (China Securities Journal, Securities Daily electronic edition, SSE disclosure); single-source items without cross-verification have been marked above. Multiple announcement originals can be verified on the Shanghai Stock Exchange website www.sse.com.cn and China Securities Journal/Securities Daily electronic editions by announcement number.

5. Stock Price Trend and Technical Analysis

5.1 Price Overview

5.2 Technical Indicators

Although the research notes list multiple market, technical analysis, and capital flow data source links, no specific price, technical indicators (moving averages, Bollinger Bands, RSI, MACD, etc.), volume, or turnover data were extracted. Therefore, it is impossible to conduct effective quantitative analysis of Xingfa Group's (600141) stock price trend and technical aspects. The notes mention that the stock once hit the daily limit due to optical fiber and storage concepts, indicating short-term theme-driven price anomalies, but there is a lack of verifiable price ranges and volume data to support further judgment. It is recommended to obtain the latest closing price, moving average system, Bollinger Bands, recent turnover, and turnover rate before re-evaluating.

5.3 Short-Term Trend Outlook (Next Week, Scenario Analysis, for Reference Only)

⚠️ Risk Warning: The following content is only a subjective scenario analysis based on currently limited information and does not constitute any investment advice. The research notes do not provide specific price and technical indicator data, and the relevant analysis is limited. Please be sure to combine the latest market information for independent judgment.

① Key Technical Levels

② Next Week Scenarios (Subjective Weighting, Not Statistical Probability)

• Consolidation (Cannot be assessed (insufficient data)): Due to lack of price, volume, and technical indicator data, specific price ranges and trigger conditions cannot be set. If the stock price subsequently maintains narrow-range fluctuations without volume support, it may manifest as a consolidation pattern. Relative weighting cannot be given based on existing data, and no subjective weighting is assigned here.
• Weaker Downside (Cannot be assessed (insufficient data)): If the stock price subsequently effectively breaks below the assumed strong support level with increased turnover, it may open downside space. However, because the research notes do not provide any support level data, specific price ranges and nameable key levels cannot be given. Relative weighting cannot be given based on existing data.
• Rebound Strengthening (Cannot be assessed (insufficient data)): The notes mention that the stock once hit the daily limit due to optical fiber and storage concepts, indicating it has theme-driven elasticity. If related themes heat up again with significantly increased turnover, a rebound strengthening may be triggered. However, due to lack of price range and volume benchmark data, specific levels and confirmation thresholds cannot be given. Relative weighting cannot be given based on existing data.

③ Capital and Liquidity Background

The research notes do not provide specific turnover rate, daily turnover range, or top ten shareholder concentration data for Xingfa Group (600141); although related source links are listed, no quotable values were extracted. Therefore, it is impossible to assess the stock's daily liquidity level and chip concentration, nor to determine whether institutional holders such as public funds, social security, or QFII have entered the top ten shareholder list. Shareholder structure data typically has a disclosure lag of more than one quarter; even if obtained later, the data cut-off date must be clearly marked and the possibility of structural changes noted. In the absence of the above data, no judgment can be made on matching depth, slippage risk, or chip stability.

Because the research notes do not provide the stock's recent normal turnover range, it is impossible to calibrate a meaningful volume confirmation threshold, so no specific turnover signal is given for now; it is recommended to obtain the recent average daily turnover and then use a significantly higher volume level as an observation signal for capital entry.

④ Points of Attention (Observation Ideas Only, Not Operational Instructions)

• Watch whether the latest closing price, moving average system (MA5/MA10/MA20), and Bollinger Bands data can be supplemented to clarify short-term resistance and support ranges
• Watch follow-up catalysts and sector linkage for the stock's optical fiber, storage, and other themes, and whether they are accompanied by significantly increased turnover
• Watch the latest disclosure of top ten shareholders and circulating shareholder structure (data cut-off date must be marked) to assess chip concentration and institutional participation
• The above are all observation ideas, not operational instructions; please combine with the latest market information for independent judgment

The above scenario analysis is based on the limited information listed in the research notes and historical price/technical indicator measurement frameworks, but the research notes do not provide specific data dates or indicator values. Short-term stock prices are also affected by multiple factors such as news, capital flows, and the broader market environment. Technical indicators themselves have lag and limitations, do not constitute a guarantee of actual future trends, and do not constitute buy/sell advice. Please combine with the latest market information for independent judgment and bear investment risks yourself.

6. Industry Landscape and Competitor Analysis

6.1 Industry Status

Xingfa Group belongs to the phosphorus chemicals industry. The research notes mention keywords such as the recovery of the glyphosate industry and stabilization of phosphate rock prices, and mention the company's entry into optical fiber and storage fields, as well as market performance such as the phosphorus chemicals concept rising sharply against the market.

6.2 Competitive Landscape

• The research notes mention the recovery of the glyphosate industry (Source: Great Wall Securities 2025 semi-annual report review).
• The research notes mention the stabilization of phosphate rock prices and the company's plan to acquire phosphate mines to further enhance resource advantages (Source: Great Wall Securities 2025 semi-annual report review, BOC Securities research report).
• The research notes mention the company's entry into optical fiber and storage fields, with the stock price hitting the daily limit (Source: eCompany/Securities Times).
• The research notes mention institutional attention to low-PE phosphorus chemicals concept stocks (Source: eCompany/Securities Times).
• The research notes mention that BOC Securities is optimistic about the company's 2026 profit recovery and growth release (Source: BOC Securities research report).

6.3 Main Competitors

The research notes do not provide specific comparison data between Xingfa Group and comparable companies in terms of production capacity scale, market share, gross margin, valuation, etc., making quantitative comparison impossible. Existing information only mentions individual dynamics such as the company's plan to acquire phosphate mines to enhance resource advantages and entry into optical fiber and storage fields, as well as industry-level information such as the recovery of the glyphosate industry and stabilization of phosphate rock prices.

7. Risk Warnings

• Risk of mismatch between operating cash flow turning from positive to negative and rapid expansion of accounts receivable: In H1 2026, net cash flow from operating activities was -RMB 733 million (same period last year +RMB 123 million), accounts receivable increased 66.64% from the beginning of the year, while revenue only grew 19.37% YoY during the same period. Accounts receivable growth significantly exceeded revenue growth. If subsequent collection falls short of expectations, it may continuously occupy the company's working capital and affect debt repayment capacity.
• Risk of continued losses in the fertilizer segment: Affected by the suspension of phosphate fertilizer exports and the supply-guarantee and price-stabilization policy, the fertilizer business showed a "price without market" pattern in H1 2026. The sulfur procurement price rose 152% YoY to RMB 4,411/ton, the fertilizer segment gross margin was -2.57% (-9.16pct YoY), and the main entity Yidu Xingfa Chemical suffered a loss of RMB 167 million. If export policy and raw material price pressures continue, this segment will continue to drag down overall profitability.
• Risk of uncertainty in the RMB 3 billion private placement implementation: This private placement was only approved by the board of directors on 2026-08-06; the shareholders' meeting has not yet been convened, and SSE review and CSRC registration have not been completed. The issue price, issue quantity (no more than 30% of total share capital before issuance, i.e., no more than 360,521,957 shares), and whether it can ultimately be implemented are all uncertain. The progress of the Qiaogou phosphate rock 2.8 million tons/year mining project and the 5 million tons/year ore dressing project (Phase I) may be delayed as a result.
• Risk of high guarantee scale: As of 2026-08-31, the company and its controlled subsidiaries had total external guarantees of RMB 20.609 billion and guarantee balance of RMB 13.492 billion, accounting for 93.64% and 61.31% of the latest audited net assets respectively. Although the announcement states there are no overdue guarantees and the guaranteed entities are mostly consolidated subsidiaries, the proportion of net assets is relatively high. If subsidiary operations fluctuate, it may have a joint impact on the company.
• Risk of continued downward revision of institutional profit forecasts: The 2026 net profit forecast range is wide (lowest RMB 1.806 billion/1.918 billion, highest RMB 2.418 billion), and multiple institutions downgraded forecasts after the semi-annual report release. Kaiyuan Securities downgraded 2026E from RMB 2.327 billion to RMB 2.034 billion, and CICC downgraded 2026/2027 forecasts by 13.8%/5.1% respectively. If the cyclical sector prosperity continues to decline, the institutional consensus may be further revised downward, thereby affecting the market's judgment of the company's valuation center.
• Risk of rising financial expenses and dilution from share capital expansion after convertible bond conversion: In H1 2026, financial expenses increased 43.22% YoY. At the same time, the early redemption of the RMB 2.8 billion "Xingfa Convertible Bond" triggered a large amount of conversion (Xingfa Convertible Bond converted 98,481,955 shares), with total share capital increasing from 1,103,257,902 shares to 1,201,739,857 shares. Although 5.5762 million repurchased shares were subsequently cancelled, the dilution effect of share capital expansion on earnings per share still requires attention.
• Risk of theme-driven stock price volatility: Due to the company's disclosure on the investor interaction platform of information such as "sodium hypophosphite production capacity for storage components of 20,000 tons/year, mastering indium phosphide synthesis technology, high-purity D4 for optical fiber," the stock price hit the daily limit and twice appeared on the Dragon-Tiger List on 2026-06-15 and 2026-06-25 (cumulative three-day price deviation reaching 20%). Such interaction platform disclosure is not a formal announcement, and the actual contribution of related businesses to performance is uncertain, with high short-term stock price volatility risk.

8. Conclusion and Outlook

In terms of growth logic, the company has three trackable main lines: First, continuous consolidation at the phosphate rock resource end, with plans to invest private placement funds in the Qiaogou phosphate rock mining and ore dressing project. The research notes mention the company's plan to acquire phosphate mines to further enhance resource advantages. BOC Securities is optimistic about the company's 2026 profit recovery and growth release, and Southwest Securities states it forecasts a compound annual growth rate of 25.06% in net profit attributable to parent over the next three years. Second, the recovery of the glyphosate industry and coordinated production cuts to support prices in the organosilicon industry bring profit recovery in basic chemical products. The 26H1 non-GAAP growth of 30.91% has partially reflected this trend. Third, extension into new materials and new energy. The company obtained an invention patent authorization related to lithium manganese iron phosphate cathode materials, signed a long-term lithium iron phosphate supply agreement with Qinghai FinDreams, and through the Three Gorges Xing'an Advanced Materials Seed Fund (contribution RMB 80 million, 40%) and the proposed Hubei Xingfa Investment Co., Ltd. (contribution RMB 76.50 million, 51%), is laying out directions such as microelectronics key chemicals and phosphorus/silicon-based high-end chemicals.

From the institutional expectation perspective, approximately 16-17 institutions issued research reports over the past six months, with ratings distributed as Buy 11-12, Overweight 4, Outperform Industry 1, with no Neutral or Reduce; the 2026 net profit forecast range is RMB 1.918 billion to RMB 2.418 billion, with an average of approximately RMB 2.146 billion to RMB 2.180 billion, corresponding to a YoY growth rate of approximately 44%-46%; the 2026 target price range is RMB 34.38 to RMB 38.94, with an average of approximately RMB 36.21-36.26. However, it should be noted that many forecasts were downgraded after the semi-annual report release. For example, Kaiyuan Securities downgraded 2026E from RMB 2.327 billion to RMB 2.034 billion due to the cyclical sector downturn since Q3, and CICC downgraded 2026/2027 forecasts by 13.8%/5.1% respectively to RMB 1.969/2.667 billion. Forecasts are still in a dynamic downward revision process, and the average has limited reference significance.

In terms of balancing risk and growth, the company's main current contradiction is the divergence between YoY performance improvement and weakening quality indicators such as cash flow, accounts receivable, and financial expenses, as well as the continued losses in the fertilizer segment squeezed by both export policy and raw material price increases. Whether the private placement can be implemented, the progress of the Qiaogou phosphate rock project, the sustainability of the glyphosate and organosilicon prosperity recovery, and the ramp-up pace of the new energy materials business will be key variables determining whether the company can achieve the institutional forecast profit recovery. Investors should combine subsequent quarterly operating cash flow and accounts receivable collection conditions to independently judge the degree of realization of the growth logic.

Data Sources

• 600141 兴发集团
• 興發集團 (600141.SH) - 快速報價
• 兴发集团(600141)_个股概览_股票价格_实时行情_走势图_新闻资讯_股评_财报_FinScope-AI让投资更简单
• 興發集團 (600141.SH)
• 600141，进军光纤、存储，股价“一”字涨停！磷化工概念逆市大涨，机构盯上这些低PE股 - 600141，进军光纤、存储，股价“一”字涨停
• 600151 航天机电
• 600151 航天机电 - 主营范围
• Hubei Xingfa Chemicals Group Co., Ltd. authorizes a Buyback Plan. - 5e2d3df9537a706ac86617.tRUpgVSfbtYpoH4yNf-k7WBgiaNqDT4XonW7cKW0nlo.31Bh6Q3-Fr1E2BVmYczSvBA_3edYQldx9APzAO7y8DD8LHr7FuYrn0uXMw
• Hubei Xingfa Chemicals Group Co., Ltd. (600141) 会社情報 - Simply Wall St - NOT FOR DISTRIBUTION
• 兴发集团获得发明专利授权：“一种高压实密度磷酸锰铁锂正极材料的制备方法”
• 兴发股份-关于兴发
• 兴发集团 600141 - 兴发集团2025年半年度业绩说明会
• 湖北兴发化工集团股份有限公司2025年年度报告摘要 - 新浪财经
• 兴发集团-首页
• 兴发集团(600141)_公司档案_中财网 - | 中财网 | 市场 | ▼ | 排行 | ▼ | 自选股
• 湖北兴发化工集团股份有限公司2024年年度报告摘要 - 2025年
• 兴发集团2025年第三季度业绩说明会 - 兴发集团2025年第三季度业绩说明会
• 中国证券报 - 湖北兴发化工集团股份有限公司 - | 第B047版：信息披露 | 上一版 下一版
• 兴发集团（600141）2026年半年度管理层讨论与分析 - 兴发集团（600141）2026年半年度管理层讨论与分析
• 兴发集团2024年度业绩说明会
• 兴发集团(600141)主营业务经营分析查询|查股网 - chaguwang.cn-查股网.中国
• 湖北兴发化工集团股份有限公司2025年年度报告摘要
• 沪深公司公告标题 - 兴发集团：湖北兴发化工集团股份有限公司2025年年度报告摘要 - 2026年4月4日 - 同花顺
• 兴发集团：湖北兴发化工集团股份有限公司2025年年度报告.PDF - 三个皮匠报告
• 兴发集团：湖北兴发化工集团股份有限公司2025年年度报告摘要.PDF - 三个皮匠报告—— 严选型全行业研究报告分享下载平台，您的专属行业智库
• 兴发集团:湖北兴发化工集团股份有限公司2025年年度报告摘要 - 首页 >
• 兴发集团：湖北兴发化工集团股份有限公司2025年年度报告-年度报告-定期财报-慧博投研资讯 - □适用√不适用十一、存在股权激励、员工持股计划的公司可选择披露扣除股份支付影响后的净利润□适用√不适用十二、采用公允价值计量的项目√适用□不适用单位：元币种：人民币项目名称期初余额期末余额当期变动对当期利润的影响金额交易性金融资产60,881,704.53...
• 兴发集团2025年年报解读 - 兴发集团2025年年报解读
• 兴发集团：湖北兴发化工集团股份有限公司2025年年度报告-其它重大事项-上市公司公告-迈博汇金 - □适用√不适用十一、存在股权激励、员工持股计划的公司可选择披露扣除股份支付影响后的净利润□适用√不适用十二、采用公允价值计量的项目√适用□不适用单位：元币种：人民币项目名称期初余额期末余额当期变动对当期利润的影响金额交易性金融资产60,881,704.53...
• 兴发集团:湖北兴发化工集团股份有限公司2025年年度报告_九方智投 - 襄阳兴发化工有限公司50000000.002025-9-262026-9-25否
• 兴发集团（600141） - 兴发集团（600141）
• 兴发集团(600141)利润表（损益表）_英为财情Investing.com - 兴发集团 (600141)
• Hubei Xingfa Chemicals Group Co Ltd (600141) 財務概覽 - 興發集團 (600141)
• 兴发集团 (600141) 毛利率 ％｜价值大师 - 简要介绍
• 集友銀行
• 中国银行(香港)有限公司
• 兴发集团(600141)业绩大全_数据中心_东方财富网
• 兴发集团 (600141.SH)
• 兴发集团 (600141.SH) - 快速报价
• Hubei Xingfa Chemicals Group (SHA:600141) Financials Overview - Hubei Xingfa Chemicals Group Co
• 长城证券-兴发集团-600141-2025半年报点评：草甘膦行业景气回暖，磷矿石价格维稳，拟收购磷矿进一步增强资源优势-250909 - 长城证券-兴发集团-600141-2025半年报点评：草甘膦行业景气回暖，磷矿石价格维稳，拟收购磷矿进一步增强资源优势-250909
• 兴发集团（600141）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大 - 兴发集团（600141）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
• 兴发集团(600141)：草甘膦行业景气回暖 磷矿石价格维稳 拟收购磷矿进一步增强资源优势 - 兴发集团(600141)：草甘膦行业景气回暖 磷矿石价格维稳 拟收购磷矿进一步增强资源优势
• 兴发集团(600141)_公司公告_兴发集团：2025年年度报告新浪财经_新浪网 - 少数股东权益 | 2,387,166,836.68 | 1,418,835,501.63
• <table><tr><td>财务指标</td><td>公司</td><td>2025/12/31</td><td>2024/12/31</td><td>2023/12/31</td></tr><tr><td rowspan="6">应收账款周转率（次）<...
• 中银证券：兴发集团（600141）-业绩稳健，看好2026年盈利修复、成长性释放 - 中银证券：兴发集团（600141）-业绩稳健，看好2026年盈利修复、成长性释放.pdf
• 中国银行(香港)有限公司 - 公司资料
• 持股 \(5\%\) 以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况口适用√不适用
• 兴发集团(600141)主要指标_兴发集团(600141)财务指标,财务分析_证券之星
• 兴发集团2024年度可视化财报
• Hubei Xingfa Chemicals Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 - 609b1c0d42bf655390b16.NN2sANjgvRD69VN-wMf0oASph8eM_RaVyrWwRW6lT34.VanZTZ-x7WeKrGNPkoOZknKa4vbYvGb9m9KHKzHUKQ5Dpesyl5aQes6cFg
• Hubei Xingfa Chemicals Group Co Ltd (600141) 손익계산서 - Investing.com
• Informações Financeiras 600141 | Hubei Xingfa Chemicals - Investing.com
• Acciones Hubei Xingfa Chemicals Group Co., Ltd. - Cotizacion 600141 Shanghai S.E. - MarketScreener - fb5.AqvMS5vM_MhIrK2rhiuk0MxoLR4PMwTaxxZp3Y_AGZI
• 兴发集团(600141)_股票行情，行情首页_中财网
• Nanyang Commercial Bank Limited - Company Information
• Podsumowanie finansowe 600141 - Investing.com
• 兴发集团(600141)_个股概览_股票价格_实时行情_走势图_新闻资讯_股评_财报_FinScope-AI让投资更简单
• 兴发集团(600141)：有机硅改善、草甘膦修复 磷矿资源持续巩固
• 兴发集团(600141.SH)：2026年中报净利润为8.36亿元、同比较去年同期上涨14.97% - 正在阅读:
• 兴发集团(600141)：26H1业绩持续增长 新建项目推进顺利
• 兴发集团(600141)：磷矿维持高景气 草甘膦、有机硅、新能源业务盈利改善 特化高端材料出货占比提升 带动26H1业绩增长 - 兴发集团(600141)：磷矿维持高景气 草甘膦、有机硅、新能源业务盈利改善 特化高端材料出货占比提升 带动26H1业绩增长
• 兴发集团：2026年上半年净利润同比增长14.97% 拟10派2元 - 兴发集团：2026年上半年净利润同比增长14.97% 拟10派2元
• 兴发集团(600141.SH)：2026年中报净利润为8.36亿元、同比较去年同期上涨14.97%
• 兴发集团半年度营业收入174.52亿元，同比增长19.37%
• [兴发